Healthcare provider profile · identity verified

Kerith W Lijewski, MD

Family Practice · RIVER FALLS, WI · NPI 1093708588

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	289	79
Lisinopril	Lisinopril	234	71
Levothyroxine Sodium	Levothyroxine Sodium	211	57
Omeprazole	Omeprazole	193	47
Amlodipine Besylate	Amlodipine Besylate	184	62
Metoprolol Succinate	Metoprolol Succinate	165	51
Gabapentin	Gabapentin	148	39
Losartan Potassium	Losartan Potassium	139	48
Pantoprazole Sodium	Pantoprazole Sodium	124	34
Furosemide	Furosemide	122	33
Simvastatin	Simvastatin	109	30
Escitalopram Oxalate	Escitalopram Oxalate	108	24
Rosuvastatin Calcium	Rosuvastatin Calcium	105	30
Trazodone Hcl	Trazodone Hcl	102	31
Sertraline Hcl	Sertraline Hcl	98	27
Trulicity	Dulaglutide	90	13
Metformin Hcl	Metformin Hcl	78	24
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	76	14
Atenolol	Atenolol	74	23
Tramadol Hcl	Tramadol Hcl	71	16
Duloxetine Hcl	Duloxetine Hcl	66	19
Eliquis	Apixaban	66	15
Metformin Hcl Er	Metformin Hcl	65	16
Prednisone	Prednisone	56	31
Venlafaxine Hcl Er	Venlafaxine Hcl	53	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	50	28
Oxycodone Hcl	Oxycodone Hcl	48	11
Alendronate Sodium	Alendronate Sodium	47	18
Clonazepam	Clonazepam	47	suppressed
Famotidine	Famotidine	47	15
Fluoxetine Hcl	Fluoxetine Hcl	47	suppressed
Xarelto	Rivaroxaban	47	11
Citalopram Hbr	Citalopram Hydrobromide	45	14
Zolpidem Tartrate	Zolpidem Tartrate	45	11
Hydrochlorothiazide	Hydrochlorothiazide	44	16
Tizanidine Hcl	Tizanidine Hcl	44	16
Warfarin Sodium	Warfarin Sodium	43	13
Potassium Chloride	Potassium Chloride	42	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	40	suppressed
Ropinirole Hcl	Ropinirole Hcl	40	suppressed
Allopurinol	Allopurinol	39	13
Synthroid	Levothyroxine Sodium	39	suppressed
Jardiance	Empagliflozin	37	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	suppressed
Lorazepam	Lorazepam	35	14
Ozempic	Semaglutide	35	suppressed
Bupropion Xl	Bupropion Hcl	32	suppressed
Chlorthalidone	Chlorthalidone	31	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	30	11
Olanzapine	Olanzapine	30	suppressed
Mounjaro	Tirzepatide	28	suppressed
Fluticasone Propionate	Fluticasone Propionate	27	suppressed
Estradiol	Estradiol	26	11
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Ondansetron Odt	Ondansetron	26	suppressed
Solifenacin Succinate	Solifenacin Succinate	26	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Montelukast Sodium	Montelukast Sodium	24	suppressed
Spironolactone	Spironolactone	24	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Cephalexin	Cephalexin	23	13
Clopidogrel	Clopidogrel Bisulfate	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	13
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Alprazolam	Alprazolam	21	suppressed
Carvedilol	Carvedilol	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	18	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	18	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Divalproex Sodium	Divalproex Sodium	18	suppressed
Propranolol Hcl	Propranolol Hcl	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	11
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Nystatin	Nystatin	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Spiriva Respimat	Tiotropium Bromide	16	suppressed
Topiramate	Topiramate	16	suppressed
Azithromycin	Azithromycin	15	14
Donepezil Hcl	Donepezil Hcl	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	suppressed
Oxycontin	Oxycodone Hcl	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Cholestyramine	Cholestyramine (With Sugar)	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Indomethacin	Indomethacin	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Minocycline Hcl	Minocycline Hcl	13	suppressed
Prenatal Vitamin Plus Low Iron	Pnv,calcium 72/Iron/Folic Acid	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Temazepam	Temazepam	13	suppressed
Tramadol Hcl Er	Tramadol Hcl	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Levocarnitine	Levocarnitine	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Risedronate Sodium	Risedronate Sodium	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error